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Introduction {#sec1}
============

The eukaryotic RNA exosome is a RNase complex that completely degrades or partially trims RNA substrates by successively cleaving their 3′ end nucleotides. The exosome is conserved from yeast to humans and acts on a wide variety of RNAs in turnover, surveillance, and processing pathways ([@bib4], [@bib11]). In the nucleus, the yeast exosome eliminates, for example, transcripts that are in excess or are defective, such as pre-mRNAs that failed to complete splicing and tRNAs that lack specific base modifications, and also destroys non-coding RNAs that are produced from leaky transcription initiation (reviewed in [@bib4], [@bib11]). Besides these destructive functions, the nuclear exosome is also involved in the maturation of rRNAs and small nuclear or small nucleolar RNAs (sn\[o\]RNAs) ([@bib1]). Defects in the nuclear functions of the exosome have been recently linked to a mutation in one of the exosome core subunits (yeast Rrp40/human EXOSC3) that is associated with a motor neuron degeneration disease ([@bib6], [@bib7]).

The processive core of the RNA exosome is a 10-protein complex (Exo-10) containing a single RNase subunit (Rrp44) and a catalytically inactive barrel (Exo-9), formed by six RNase PH-like proteins and three S1-KH "cap" proteins (reviewed in [@bib27]). Using biochemical and structural studies on the *S. cerevisiae* complex, we have previously shown that an RNA substrate is channeled from the entry pore at the top of Exo-9 to the Rrp44 exoribonuclease site via an internal conduit that is spanned by about 30 nucleotides ([@bib2], [@bib15]). The 30-nucleotide footprint of Exo-10 in vitro is reminiscent of a pre-rRNA processing defect common to yeast strains lacking functional nuclear exosome cofactors, namely the accumulation of a 5.8S rRNA precursor with a 3′ extension of 30 nucleotides (reviewed in [@bib3]).

Studies over the last two decades have converged on four conserved nuclear exosome cofactors: Rrp6; Rrp47; Mtr4; and Mpp6 (reviewed in [@bib3], [@bib11]). Rrp6 and its interacting partner Rrp47 are constitutively bound nuclear exosome subunits. Rrp6 contains a distributive 3′-5′ RNase domain that is positioned at the top of Exo-9 barrel ([@bib15], [@bib25], [@bib28]). Rrp47 does not have enzymatic activity but, together with Rrp6, forms a binding platform for recruiting Mtr4 ([@bib21]). Mtr4 is an essential helicase believed to assist the exosome by presenting it with suitably remodeled substrates that can be threaded with their unwound 3′ end into the degradation core ([@bib10], [@bib16]). In contrast to Rrp6, Rrp47, and Mtr4, there is currently no mechanistic structural information on Mpp6, a small basic protein lacking recognizable domains. Yeast Mpp6 is physically associated with the nuclear exosome in vivo ([@bib18]) and in vitro ([@bib21]) and is expected to bind near the cap protein Rrp40 ([@bib22]). The precise role of Mpp6 in the nuclear functions of the exosome has remained elusive. In this work, we set out to shed light on the mechanisms with which yeast Mpp6 binds to and cooperates with the exosome.

Results and Discussion {#sec2}
======================

Yeast Mpp6 Binds the Exosome Core with High Affinity via the Middle Domain {#sec2.1}
--------------------------------------------------------------------------

We had previously shown that *S. cerevisiae* Mpp6 binds Exo-9 independently of Rrp6-Rrp47 and Rrp44 ([@bib21]). To obtain a quantitative measure of the binding affinity, we introduced a single cysteine residue near the C terminus of full-length Mpp6 (Mpp6^FL^ S184C substitution), labeled the purified protein with a cysteine-reactive fluorophore (red-maleimide) and performed microscale thermophoresis (MST) to analyze in the interaction with Exo-9. The MST measurements revealed that the Mpp6--Exo-9 dissociation constant is in the high nanomolar range (*K*~d~ ∼82 nM; [Figure 1](#fig1){ref-type="fig"}A), indicating a relatively tight binding, albeit one order of magnitude weaker than that of Rrp6 ([@bib12]). Next, we compared endogenous nuclear exosomes purified from yeast strains genetically engineered to contain a Twin Strep-ProtA tag (TSPA) at the C terminus of either Mpp6 or Rrp6. In addition to tagging the nuclear cofactors, we also engineered strains with TSPA-tagged Ski7 (the cytoplasmic cofactor whose binding to Exo-9 is mutually exclusive with that of Rrp6; [@bib12]) and TSPA-tagged Rrp44 (the ubiquitous RNase that is present both in the nuclear and cytoplasmic exosome complexes). As expected, tandem-affinity purifications from the strain expressing Rrp44-TSPA yielded the exosome subunits, the cytoplasmic cofactor Ski7, and the nuclear cofactors Rrp6, Rrp47, and Mpp6 ([Figure 1](#fig1){ref-type="fig"}B, lane 5), whereas purifications from a strain expressing Ski7-TSAP precipitated the exosome core, but not the nuclear cofactors ([Figure 1](#fig1){ref-type="fig"}B, lane 6). In purifications from the Rrp6-TSPA-tagged strain, we detected the exosome subunits, Rrp47 and Mpp6 ([Figure 1](#fig1){ref-type="fig"}B, lane 7). Vice versa, purification using Mpp6-TSPA yielded the exosome, Rrp6 and Rrp47 ([Figure 1](#fig1){ref-type="fig"}B, lane 8). Thus, Mpp6 and Rrp6-Rrp47 can be part of the same endogenous exosome complexes. As a note, Mpp6 appears to be sub-stoichiometric with respect to other exosome components, either due to technical issues or its estimated lower abundance ([@bib13]). None of the purifications resulted in a significant co-precipitation of Mtr4 in the conditions we used ([Figure 1](#fig1){ref-type="fig"}B, lanes 5--8), suggesting that this is a transiently associated rather than a constitutively bound cofactor of the nuclear exosome.Figure 1Mpp6 Binds with High Affinity to the Exo-9 Core via the Middle Domain(A) The binding of Mpp6 to the Exo-9 core was measured with MST. The titration of Exo-9 ranged from 1.5 nM to 50 μM with a constant concentration of labeled Mpp6-S184C at 50 nM. Data were analyzed by thermophoresis and temperature jump mode. The error bars represent the SD of each data point calculated from three independent measurements.(B) Tandem-affinity purification of exosome complexes using different bait proteins C-terminally tagged with a Twin Strep-ProtA tag (TSPA). Eluates were TCA precipitated and analyzed on 12% SDS-PAGE and stained with Instant Blue (Expedeon). Lanes 1--4 correspond to the flowthrough, and lanes 5--8 correspond to the elution.(C) Schematic domain organization of yeast Mpp6, with the three domains (N-terminal, middle, and C-terminal) indicated. The conserved sequence motif of the middle domain is shown below the schematic representation (red box). The sequence alignment includes orthologs from the representative species. The level of conservation is indicated by color, from dark blue (high conservation) to white (no conservation). Above the sequence, residues of Mpp6~M~ that interact with the Rrp40 are labeled with a salmon circle.(D) Protein co-precipitations by GST pull-down assays. GST-tagged yeast Mpp6^FL^ and truncations were purified and mixed with purified Exo-9. Pull-down assays were carried out using GSH-Sepharose beads in a buffer containing 100 mM NaCl. The Coomassie-stained 12% SDS-PAGE gels show the input (lanes 1--7) and the pulled-down protein precipitates (lanes 8--14). Black dots denote the bait protein.

Next, we mapped the domain of Mpp6 responsible for binding Exo-9. *S. cerevisiae* Mpp6 (186 residues) is an intrinsically disordered protein ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). The N-terminal two-thirds of Mpp6 are evolutionary conserved, particularly at two hotspots between residues 11--21 and 111--115 ([@bib18]; [Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}C). The C-terminal third is generally less conserved and contains a high percentage of positively charged residues. We purified several versions of glutathione S-transferase (GST)-tagged Mpp6 proteins and tested their interaction with untagged Exo-9 in pull-down assays with glutathione-agarose beads ([Figure 1](#fig1){ref-type="fig"}D). Removal of the C-terminal region of Mpp6 still allowed efficient binding to Exo-9 (Mpp6^1--122^; [Figure 1](#fig1){ref-type="fig"}D, lane 9). However, a further C-terminal truncation (Mpp6 residues 1--110) impaired binding in the pull-down assay ([Figure 1](#fig1){ref-type="fig"}D, lane 10), suggesting the conserved 111- to 115-residue hotspot ([@bib18]) is involved in Exo-9 binding. Next, we truncated Mpp6 from the N terminus to progressively remove patches of conserved residues ([Figures 1](#fig1){ref-type="fig"}D, lanes 11--13, and [S1](#mmc1){ref-type="supplementary-material"}C). We found that Mpp6 could be truncated to residues 83--122 and still interact with Exo-9 ([Figure 1](#fig1){ref-type="fig"}D, lane 12). However, a further truncation to residues 91--122 impaired binding ([Figure 1](#fig1){ref-type="fig"}D, compare lanes 12 and 13), suggesting that the 111- to 115-residue hotspot is not sufficient for Exo-9 binding. We concluded that the middle domain of Mpp6 (residues 83--122 or Mpp6~M~) contains the major Exo-9-binding determinants ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}C). We proceeded to obtain the three-dimensional structure of a minimal Exo-9--Mpp6 complex.

Overall Structure of Exo-9 Bound to Mpp6 {#sec2.2}
----------------------------------------

Although we could obtain several crystal forms from Mpp6-containing exosome samples, upon solving these structures, we could only observe density for Exo-9. We reasoned that crystal-packing interactions might interfere with Mpp6 binding. From previous crosslinking and mass-spectrometry experiments, Mpp6 was expected to reside in close proximity to Rrp40 ([@bib22]). Inspection of all crystal forms we had obtained indeed revealed that a surface of Rrp40 was involved in lattice interactions with an Rrp4 subunit from an adjacent complex in the crystal lattice ([Figure S2](#mmc1){ref-type="supplementary-material"}A). To disrupt this contact without affecting Rrp40, we introduced mutations on the surface of Rrp4 involved in crystal packing (I66E, M68E, or Rrp4mut). The Exo-9~Rrp4mut~--Mpp6 complex yielded diffracting crystals with four copies of the complex in the asymmetric unit ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Inspection of the map showed density for Mpp6~M~ in two of the four copies. The final model was refined to 3.2 Å resolution with R~free~ of 26.2% and good stereochemistry ([Table 1](#tbl1){ref-type="table"}).Table 1Crystallographic Data Collection and Refinement StatisticsDatasetExo-9~Rrp4mut~--Mpp6~M~Space groupP2~1~Cell dimensions*a*, *b*, *c* (Å)166.8, 237.4, 201.9*α*, *β*, *γ* (°)90.0, 110.4, 90.0Data CollectionWavelength (Å)1.25Resolution (Å)151.20--3.20No. of reflections996,533No. of unique reflection229,497*R*~merge~ (%)24.3 (229.9)*R*~*pim*~ (%)11.4 (129.8)*I/σI*5.7 (0.6)Completeness (%)97.7 (79.9)Multiplicity4.3CC~1/2~98.5 (24.3)RefinementResolution (Å)80.76--3.20 (3.31--3.20)No. of unique reflections229,411*R*~work~/*R*~free~ (%)22.5/26.2Wilson B factor (Å^2^)72.27Average B factors (Å^2^)95.3No. of AtomsProteins66,857Ligands53StereochemistryRoot-mean-square deviation (RMSD) bond lengths (Å)0.003RMSD bond angles (°)0.52Ramachandran favored (%)96.0Ramachandran outliers (%)0.4

In the Mpp6-bound structure, Exo-9 has the typical barrel-like architecture that has been previously described for other exosome complexes, with a ring of six RNase PH-like proteins (Mtr3-Rrp42-Rrp41-Rrp45-Rrp46-Rrp43) capped by a ring of three S1/KH proteins (Rrp4, Rrp40, and Csl4; [@bib12], [@bib14], [@bib15], [@bib17], [@bib25], [@bib28]). The most significant difference with previous X-ray structures is that the density for Csl4 is generally not well defined, in line with the increased flexibility of this subunit in the absence of Rrp6 ([@bib15], [@bib24]). Mpp6~M~ binds on the surface of the Rrp40 subunit with two extended segments ([Figure 2](#fig2){ref-type="fig"}A).Figure 2Crystal Structure of Mpp6 Middle Domain Bound to Exo-9 (to Rrp40)(A) Crystal structure of the *S. cerevisiae* Exo-9--Mpp6 complex (shown in a "front" view). The RNase PH-like core is in gray and the cap proteins Csl4, Rrp4, and Rrp40 in yellow, orange, and salmon, respectively. Mpp6 is shown in cyan, and the N- and C-termini of Mpp6 are indicated.(B) Zoom-in views of the Mpp6-Rrp40 interaction interface at the long region in the same colors as in (A). Conserved residues involved in the interaction are shown in stick representation.(C) Protein co-precipitations with GST-tagged yeast Mpp6^FL^ and Mpp6 R112E/F115A (Mpp6-Mut). The pull-down assays were carried out as in [Figure 1](#fig1){ref-type="fig"}D. The Coomassie-stained 12% SDS-PAGE gels show the input (lanes 1 and 2) and the pulled-down protein precipitates (lanes 3 and 4).(D) Protein co-precipitations with Trx-eGFP-tagged human MPP6 residues 40--83 (Trx-hMPP6^40--83^-eGFP) and MPP6 R74E/F77A (Trx-hMPP6^40--83^-Mut-eGFP). The pull-down assays were carried out using GFP-binder Sepharose beads in a buffer containing 100 mM NaCl. The Coomassie-stained 12% SDS-PAGE gels show the input (lanes 1 and 2) and the pulled-down protein precipitates (lanes 3 and 4).(E) Protein co-precipitations with Trx-eGFP-tagged human MPP6 residues 40--83 (Trx-hMPP6^40--83^-eGFP) and purified hEXO-9 (either wild-type or hExo-9-Rrp40^W238R^). Pull-down assays were carried out using GFP-binder Sepharose beads in either 100 mM or 500 mM NaCl. The Coomassie-stained 12% SDS-PAGE gels show the input (lanes 1 and 2) and the pulled-down protein precipitates (lanes 3--6).

The Mpp6 Middle Domain Wraps around Rrp40 with Evolutionary Conserved Interactions {#sec2.3}
----------------------------------------------------------------------------------

Rrp40 contains three domains. The N-terminal domain is an all β-fold that binds on top of the Rrp46 subunit ([@bib14]). The central S1 domain is a β-barrel characteristic of oligonucleotide/oligosaccharide-binding (OB)-fold proteins. The C-terminal domain is a type 1 KH domain, with a 3-stranded β-sheet packed against an α-helical bundle ([@bib19]). The KH β-sheet packs against the S1 domain, forming a single structural module that binds across the top of Rrp45, with the KH domain positioned on the outside of the ring and the S1 domain on the inside.

The longer segment of Mpp6 binds in a pocket formed between the S1 and KH domains of Rrp40 and could be unambiguously assigned to residues 108--117 ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}C). This segment starts with van der Waal contacts of Ile109~Mpp6~ with the first helix of the KH domain (at Leu167~Rrp40~ and Phe168~Rrp40~). It continues with a sharp 90° turn at Gly111~Mpp6~ and ends with a β-strand that packs against and extends the β-sheet of the KH domain. The side chains of Lys113~Mpp6~ and Phe115~Mpp6~ protrude on one side of the β-strand toward the KH helical bundle and bind in a hydrophobic pocket lined by Phe184~Rrp40~, Val186~Rrp40~, Ile188~Rrp40~ and Leu175~Rrp40~, Ala179~Rrp40~. The side chain of Arg112~Mpp6~ protrudes on the other side of the β- strand toward the S1 domain, engaging the aliphatic portion in apolar contacts with Tyr120~Rrp40~ and Leu150~Rrp40~ and engaging the guanidinium group in an electrostatic interaction with Glu185~Rrp40~. Consistent with the structural analysis, mutation of Arg112~Mpp6~ and Phe115~Mpp6~ (R112E, F115A mutant) impaired the interaction of Mpp6^FL^ with Exo-9 in pull-down assays with recombinant proteins ([Figure 2](#fig2){ref-type="fig"}C, compare lanes 3 and 4).

In the case of the shorter segment of Mpp6, the interpretation of the density was rather ambiguous. This segment extends on a conserved surface of the Rrp40 N-terminal domain (above the Leu21-Gly22-Pro23-Gly24 loop) and contacts the edge of the KH helical bundle (at Arg164, Phe168). Guided by the density features of Mpp6, sequence conservation, results of the mapping experiments ([Figure 1](#fig1){ref-type="fig"}D), and by chemical considerations, we tentatively assigned the sequence of the Mpp6 shorter segment to residues 90--99 ([Figure S2](#mmc1){ref-type="supplementary-material"}D). The structural model is consistent with geometric restraints deduced from previous mass spectrometry-crosslinking data (e.g., a distance of less than 30 Å between crosslinked Mpp6 Lys104--Rrp40 Lys49 and between crosslinked Mpp6 Lys113--Rrp40 Lys176; [Figure S2](#mmc1){ref-type="supplementary-material"}E; [@bib22]).

The Human EXOSC3 W238R Disease Mutation Affects Binding of Mpp6 {#sec2.4}
---------------------------------------------------------------

The evolutionary conservation of the *S. cerevisiae* Mpp6-Rrp40 interactions suggested that the human orthologs hMPP6-EXOSC3 engage in a similar binding mode. Mutations of human Rrp40 (EXOSC3) are associated with pontocerebellar hypoplasia, a severe and often deadly motor neuron disease in children ([@bib23]). The most severe phenotypes are linked to the mutation of Trp238~EXOSC3~ to arginine ([@bib23]). Previous studies have shown that the corresponding mutation of yeast Trp195~Rrp40~ to arginine (W195R) affects cell growth and impacts specifically on the nuclear functions rather than the cytoplasmic functions of the exosome ([@bib6]), particularly rRNA processing ([@bib7]). From the Exo-9--Mpp6 structure, the yeast Rrp40 W195R mutation is predicted to cause an unfavorable and likely incompatible electrostatic environment for accommodating Arg112~Mpp6~ (corresponding to human hMPP6 Arg74). We tested the effect of mutating hMPP6 and EXOSC3 in in vitro binding experiments with recombinant proteins. Whereas the middle domain of hMPP6 interacted with human EXO-9 in the pull-down assays, an hMPP6 mutant containing the R74E, F77A substitution failed to do so ([Figure 2](#fig2){ref-type="fig"}D), similarly to the results we had obtained with the corresponding yeast Mpp6 R112E, F115A mutant ([Figure 2](#fig2){ref-type="fig"}C). Next, we reconstituted a human hEXO-9 complex containing the W238R disease mutation. Under low ionic strength conditions (100 mM NaCl), the interaction between hMPP6 and hEXO-9 mutant was weakened ([Figure 2](#fig2){ref-type="fig"}E, compare lanes 3 and 5). Applying more stringent washing conditions (e.g., increasing the ionic strength to 500 mM NaCl) strongly reduced the binding of hMPP6 to the hEXO-9 mutant ([Figure 2](#fig2){ref-type="fig"}E, compare lanes 4 and 6). This suggests that the EXOSC3 W238R mutant destabilizes the hMPP6-binding surface of EXOSC3, providing a mechanistic explanation for the impact of this mutation on the functions of the nuclear exosome. Whether hMPP6 recruitment is the ultimate deficit in pontocerebellar hypoplasia patients remains unclear, because in human cells, the hMPP6-binding surface could in principle be used to recruit another nuclear cofactor and destabilization of this surface might also lead to instability of the protein in vivo ([@bib6]).

The Presence of Mpp6 in the Nuclear Exosome Supports Efficient RNA Channeling through Mtr4 {#sec2.5}
------------------------------------------------------------------------------------------

How does Mpp6 binding on top of the exosome core impact on the biochemical properties and functions of the nuclear exosome? Because Mpp6 has been shown to have RNA-binding properties ([@bib18], [@bib20]), we analyzed its contribution to the nuclear exosome complex using RNase protection assays ([Figures 3](#fig3){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}). Using these assays, we have previously shown that yeast Exo-10 has an RNA-binding footprint of about 30 nucleotides ([@bib2]), reflecting the RNA-binding path in the internal channel of Exo-10 ([@bib15]). The presence of Rrp6-Rrp47 on Exo-10 intensified but did not shift the size of the protected fragments ([Figure 3](#fig3){ref-type="fig"}A, lanes 2 and 3). This is consistent with the stabilizing effects of Rrp6 ([@bib15]) and with the features of the Exo-10--Rrp6--Rrp47 (Exo-12) structure ([@bib17]). Addition of the Mtr4 helicase led to a partial shift to 45-nucleotide-long RNA fragments but only in the presence of ADP (compare lane 8 and lane 5). Further addition of Mpp6 completely shifted the protection pattern to the 45-nucleotide fragments in the presence of ADP (lane 9). Because Mtr4 is an ATP-dependent RNA helicase, we speculate that productive RNA binding and channeling depends on the presence of nucleotides.Figure 3Mpp6 Supports Efficient RNA Channeling through the Mtr4--Exosome Complex(A) RNase protection patterns of the nuclear exosome. A single-stranded (C^∗^U)~28~C RNA, internally ^32^P-labeled at the uridine phosphate, was incubated with different combinations of components of the nuclear exosome as indicated and treated with RNase A/T1 (as in [@bib2]). The reaction products were analyzed by denaturing PAGE and phosporimaging. RNA fragments of ∼30-nt length accumulated in the presence of Exo-10 and Exo-12. Longer RNA fragments of ∼45 nt accumulated in the presence of Exo-12 and Mtr4, ADP, and Mpp6.(B) Model of Mtr4 recruitment and RNA targeting to the nuclear exosome complex. The model recapitulates structural features and interactions of nuclear exosome components from this work and from previous studies ([@bib26], [@bib9], [@bib15], [@bib17], [@bib21], [@bib25], [@bib28]).

These results suggested that, in the context of 14-subunit complex, Mpp6 helps recruiting or holding Mtr4 in a conformation whereby the helicase channel can form a continuous conduit with the exosome core. To confirm the presence of an Mtr4-channel-dependent path to the exosome, we introduced an unfavorable negative charge by substituting a conserved RNA-binding residue in the helicase channel (Thr502Asp; [@bib26]). The presence of the Mtr4 T502D mutant indeed impaired the 45-nucleotide pattern (lane 10), leading to an intermediate shift (whose significance is currently unclear). Interestingly, the C-terminal domain of Mpp6 could be removed without affecting the accumulation of the 45-nucleotide fragments (Mpp6^1--122^; lane 11). However, the Exo-9-binding domain of Mpp6 (Mpp6~M~; residues 83--122) was not as efficient as the fragment encompassing residues 1--122 in promoting the accumulation of the 45-nucleotide fragments, suggesting that the N-terminal domain contributes to hold Mtr4 in the RNA-channeling conformation on top of the exosome core, although the detailed mechanisms are currently unclear.

In summary, the emerging picture from our study is that Mpp6 stably binds Exo-12 to form a nuclear exosome population (Exo-13) that can effectively recruit the more transient fourteenth subunit, Mtr4 ([Figure 3](#fig3){ref-type="fig"}B). We speculate that, in an endogenous context, protein-protein interactions might not be sufficient to recruit Mtr4 and that the helicase might have to be productively engaged with an RNA substrate to be efficiently targeted to the nuclear exosome. Such targeting would in turn result in the channeling of the RNA substrate from the unwinding helicase to the processive RNase of the nuclear exosome complex.

Experimental Procedures {#sec3}
=======================

See the [Supplemental Information](#app3){ref-type="sec"} for detailed methods.

Recombinant Protein Expression and Purification {#sec3.1}
-----------------------------------------------

Exosome proteins and cofactors were expressed and purified as previously described ([@bib5], [@bib8], [@bib15]). The yeast Exo-9--Mpp6 complex was reconstituted by mixing Exo-9 with 1.2-fold molar excess of Mpp6 full-length followed by gel filtration. Human MPP6 residues 40--83 were tagged with an N-terminal His~6~-thioredoxin-tag (His-Trx) and a C-terminal eGFP-StrepII-tag.

Endogenous Protein Purification {#sec3.2}
-------------------------------

All yeast strains generated here are derivatives of the base strain BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0). General yeast manipulations were conducted by standard methods.

Biochemical Assays {#sec3.3}
------------------

Pull-down assays with GST-tagged *S. cerevisiae* Mpp6 were carried out with GSH Sepharose (GE Healthcare). Pull-down assays with GFP-tagged human MPP6 were carried out with GFP binder resin. The tagged bait proteins were incubated with 1.2 molar excess of untagged prey (Exo-9) and washed three times with a buffer containing either 100 mM or 500 mM NaCl. RNase protection was carried out as previously described ([@bib2]).

Biophysical Assays {#sec3.4}
------------------

The microscale thermophoresis experiments were carried out with Mpp6 S184C labeled with red maleimide incubated with increasing concentrations of unlabeled Exo-9 in a buffer containing 150 mM NaCl. Thermophoresis was measured with an light-emitting diode (LED) power of 40% and standard parameters on a NanoTemper Monolith NT.115 machine. Titrations were performed in triplicates, and the data were analyzed using the Thermophoresis and T-Jump strategy option with the MO software (NanoTemper Technologies).

Crystallization and Structure Determination {#sec3.5}
-------------------------------------------

The best diffracting crystals of the Exo-9--Mpp6 complex were obtained at 12 mg/mL in 0.1 M Tris/Mops (pH 7.5), 30 mM MgCl~2~, 30 mM CaCl~2~, and 30% polyethylengylcol (PEG) 8000/ethylene glycol. X-ray data were collected at 100 K at the beamline PXII (X10SA) of the Swiss Light Source (SLS) (Villigen, Switzerland). The structure was solved by molecular replacement of the coordinates of Exo-9 from PDB [5JEA](pdb:5JEA){#intref0010} ([@bib12]). Data processing, phasing, model building, and refinement were carried out with standard programs (as detailed in [Supplemental Information](#app3){ref-type="sec"}).
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Accession Numbers {#app1}
=================
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